Displaying 10 out of 28 results

  1. FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the

    AstraZeneca's combo drug for lung cancer succeeds in late-stage trial

    AstraZeneca Plc said on Monday a combination of its cancer drug, Imfinzi, along with chemotherapy helped curb progression of lung cancer in a ...
  2. FILE PHOTO: A man exercises on steps near the Lincoln Memorial in Washington

    Current and ex-smokers may lower lung cancer risk with exercise: Study

    Men who are current or former smokers may be less likely to develop or die from lung cancer when they're more physically fit, a recent study suggests.
  3. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse

    Bristol-Myers immunotherapy combo outperforms chemo in lung cancer survival: study

    About 40per cent of patients who received a combination of Bristol-Myers Squibb Co's immuno-oncology drugs Opdivo and Yervoy as an initial ...
  4. New Content Item

    E-sniffer predicts non-responders to lung cancer immunotherapy

  5. New Content Item

    Amgen drug shrinks lung cancer tumors in half of patients: study

  6. Swiss drugmaker Novartis' logo is seen in Stein

    Novartis wins FDA's breakthrough tag for lung cancer hopeful

    Novartis has secured the U.S. Food and Drug Administration's Breakthrough Therapy Designation for its investigational medicine capmatinib, which ...
  7. New Content Item

    AstraZeneca's Tagrisso gets China OK for type of lung cancer

  8. A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stoc

    AbbVie terminates late-stage lung cancer trial

    AbbVie Inc on Thursday said it will discontinue the late-stage trial testing its experimental treatment for a type of lung cancer after it failed ...